Meditrina Hellas

Meditrina Hellas is a Greek pharmaceutical company specializing in the marketing and distribution of innovative pharmaceutical products, medical devices, and food supplements. Established in 2005, the company has built a strong presence in the Greek healthcare market, particularly within the therapeutic areas of urology, gynecology, oncology, and hematology. Meditrina acts as a strategic partner for international firms, such as Kedrion Biopharma and IBSA, distributing a wide range of plasma-derived therapies and specialized medicines. Their portfolio includes treatments for benign prostatic hyperplasia, urinary tract infections, and various oncology-related supportive care products. The company is headquartered in Halandri, Greece, and is an active member of the Hellenic Association of Pharmaceutical Companies.